SAN DIEGO, May 22, 2012 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the thirteen abstracts relating to its proprietary

New research being presented at Digestive Disease Week® (DDW) offers key insights into the prevention and treatment of bowel diseases, which affect millions of people worldwide.

SAN DIEGO, May 21, 2012 /PRNewswire/ -- New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI® (golimumab)

Canada has one of the highest prevalence of IBD in the world with one in 160 Canadians living with IBD and 9,200 new cases diagnosed each year* MONTREAL, May 15, 2012 /CNW/ -

According to court documents, on April 18th, 2012, the Accutane side effects lawsuit filed by Alton Herbert was transferred to the current Accutane Multi District Litigation (MDL 1626) in the